Trinity transforms decades of strategic expertise into dynamic, data-driven customer models that help life sciences organizations anticipate market shifts and make smarter commercial decisions in real time.

WALTHAM, Mass.: Trinity today announced broad launch of InsightsEDGE™ | Digital Twins, a market tested AI-solution that creates interactive virtual replicas of HCPs, patients, and payers, grounded in real data and continuous learning.

The solution extends Trinity's InsightsEDGE platform, transforming disconnected, one-and-done insights into always-on customer understanding - enabling commercial teams to make faster, more targeted decisions without commissioning a new study every time.

Built by researchers, for researchers, Digital Twins combine Trinity’s 30+ years of life sciences market research and analytics pedigree with advanced AIML to create interactive, data-grounded virtual replicas of key customers that are designed to update with new insights and can be engaged via natural language conversations with voice, text, or generative video. ​ Unlike generic digital personas, Trinity rigorously calibrates and tests their offering against primary market research and real data, delivering precise, context-specific answers that reflect the nuances of each therapeutic area and client need. ​

Digital Twins are continuously learning, powered by Weave, Trinity’s proprietary AI-powered unified data fabric. Digital Twins integrate primary market research, prescription claims, EMR/EHR, CRM, field feedback, and differentiated datasets like Trinity Digital Affinity, at the n=1 level (individual level). ​ Trinity Weave learns the connections between the various disparate sources of data, then scales those insights across entire HCP, patient, or payer universe to generate an AI-enhanced data fabric that serves as the backbone for each instance of InsightsEDGE | Digital Twins. ​

Every new Insights & Analytics study, updated real data, customer engagement initiative, and piece of field feedback is dynamically integrated, so the Digital Twins get smarter with every data point. ​ This creates a closed-loop system in which insights, analytics, and field teams all work from the same dynamic source of truth. ​

“Biopharma companies invest millions in research, analytics, and field insights, but too often those assets end up trapped in decks and disconnected databases,” said Jonathan Jenkins, Head of Digital & AI Solutions, Trinity. ​ “Trinity’s Digital Twins change that by unifying primary and secondary data at the individual customer level and making it usable in real time, so teams can hyper-personalize engagement, simulate real conversations in virtual environments, and make better decisions faster.” ​

In keeping with Trinity’s commitment to regulatory compliance and data protection, Digital Twins are built on an enterprise-grade security and governance framework. ​ The solution can be deployed within client firewalls, supports strict role-based access controls, and incorporates robust data sanitization to prevent exposure of personally identifiable information and protect client intellectual property. ​ All models and workflows are designed to align with applicable industry regulations and internal review processes, enabling clients to safely leverage AI while maintaining compliance with promotional, privacy, and pharmacovigilance requirements. ​

“Because our Digital Twins are grounded in Trinity research and compliant client data, they don’t just sound plausible, they reflect how real stakeholders think and behave,” said Amod Athavale, Executive Director, Head of Integrated Insights, Trinity. “With the safeguards, governance, and deployment options our clients expect from InsightsEDGE, they can trust the outputs, move faster, and make better commercial decisions at scale with confidence.”​

Digital Twins help life sciences organizations address these pressing challenges: ​

• Advance rapid market research: Run on demand testing new or updates data, target product profiles, value messages, and concepts in virtual environments without commissioning new studies every time.​

• Accelerate pre-call planning: Give field teams conversational tools to anticipate what specific customers may say or object to, so pre-call planning is tailored instead of generic and time-consuming.​

• Simulate impacts of new market events: Test “what if” scenarios and the impact that they may have on customer attitudes, perceptions, intentions, and expected behaviors.

Deploy Digital Twins independently for on-demand questions, or pair with novel primary market research for richer, validated insights.

• Market Research Digital Twins: Test faster. Learn more. Commission less. Purpose-built synthetic personas for message development, concept testing, target product profiles, competitor scenarios, and new data readouts.

• Patient Digital Twins: Understand the patient behind the data. Build a comprehensive view of patient needs, behaviors, preferences, and treatment outcomes for patient-centered strategies.

• Payer Digital Twins: Pressure-test your value story before the access meeting. AI agents trained on Trinity's proprietary payer research to refine value messaging and rehearse objection handling.

• HCP Digital Twins: Connect attitudes and behavior to engage better. Sales and MSL teams engage synthetic personas to understand prescribing motivations, competitive perceptions, and what outreach will resonate.

Fully integrate into existing analytics platforms, CRM, and field tools for always-on intelligence across your commercial team.

Digital Twins are now generally available to life sciences companies globally as part of Trinity’s broader InsightsEDGE and Trinity AI portfolio, which powers a large share of the firm’s insights and analytics work across leading pharmaceutical and biotech organizations. ​

To see InsightsEDGE | Digital Twins in action or co-create a rapid protype with your data, visit https://trinitylifesciences.com/products/insightsedge-digital-twins/ or contact info@trinitylifesciences.com.

About Trinity

Trinity powers the future of life sciences commercialization through the fusion of human and artificial intelligence. By blending deep therapeutic expertise and trusted human ingenuity with a purpose-built technology platform, Trinity accelerates clarity and confidence at every step of the commercialization journey-from pre-launch to scale to loss of exclusivity. For more than 30 years, the world’s leading pharmaceutical, biotech, and medtech companies have relied on Trinity’s foresight, execution, and partnership to deliver confident product launches, decisive market advantage, and measurable patient impact. During that time, Trinity expanded from its first office in Waltham, MA to 1,300 professionals across 14 offices and five continents, setting new industry standards in quality, responsiveness, and client partnership. For more information, visit Trinity at www.trinitylifesciences.com.

Fonte: Business Wire